1. Chopra HK
2. Singh Harmeet
3. Sharma Srikant
4. Patel Nisarg

9789389587890

10.5005/jp/books/18422_9

1/e

2020

12

1. Moolchand Medcity Hospital, New Delhi, India, Medanta Moolchand Heart Institute, Moolchand Medcity, New Delhi, India, Medanta Moolchand Heart Institute, Moolchand Medcity; World Wellness Foundation, WHA; AHA, Medanta Moolchand Heart Institute; Moolchand Medcity; World Wellness Foundation, WHA; CSI & IAE; IHJ, JIAE, Medanta Moolchand Heart Institute; Moolchand Medcity; World Wellness Foundation, WHA, Medanta Moolchand Heart Institute, New Delhi, India; CME, Moolchand Medcity, World Wellness, Foundation and WHA; AHA; CSI and IAE; IHJ and JIAE, IAE-2017, CSI-2015; World Wellness Foundation, Country Head, American Heart Association; Medanta Moolchand Heart Institute; Health Committee, SCOPE, Tata Sky FAM Health, New Delhi, India, IAE- 2017, CSI -2015; World Wellness Foundation; American Heart Association; Moolchand Medcity; Physician Governing Body, CME, COP Moolchand Medcity, New Delhi, India, IAE- 2017, CSI -2015; World Wellness Foundation; Physician Governing Body, CME, COP Moolchand Medcity, New Delhi, India
2. Moolchand Medcity, New Delhi, India
3. Moolchand Medcity, New Delhi, India
4. Moolchand Medcity, New Delhi, India

Heart failure, biomarker, diagnostic, prognostic, therapeutic implication, natriuretic peptide, d-type natriuretic peptide, DNP, neutral endopeptidase, renal sympathetic system, diagnostic implication, prognostic implication